HCW Biologics Inc.(HCWB)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

HCW Biologics Inc. (HCWB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HCWB at 30.3/100 on a 32-signal composite quality model, placing it at rank #2,493 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of HCWB by reported 13-F value include JANE STREET GROUP, CITADEL ADVISORS, HRT FINANCIAL, based on the most recent SEC filings. HCWB trades on the Nasdaq exchange and files with the SEC under CIK 1828673. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HCWB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for HCW Biologics Inc. directly from SEC EDGAR.

AI Quality Score

30.3/100

AI Rank

#2,493

Net Income

$-5.2M

HCWB key financials by period

HCW Biologics Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$54.2K$-8.0M—
FY 202410-K$2.6M$-30.0M—
FY 202310-K/A$2.8M$-25.0M—
FY 202210-K/A$6.7M$-14.9M—
FY 202010-K$4.1M$-5.8M-142.1%

Institutions holding HCWB

Institutional investors reporting a position in HCW Biologics Inc. on SEC Form 13F.
InstitutionSharesValueReported
JANE STREET GROUP52,138$260.2K2026-06-30
CITADEL ADVISORS19,942$99.5K2026-06-30
HRT FINANCIAL13,583$67.0K2026-06-30
VANGUARD FIDUCIARY6,510$32.5K2026-06-30
Tower Research Capital (TRC)4,117$20.5K2026-06-30
Connective Capital Management3,338$16.7K2026-06-30
VANGUARD CAPITAL MANAGEMENT2,003$10.0K2026-06-30
Golden State Wealth Management1,667$8.3K2026-06-30
BARCLAYS PLC191$953.002026-06-30
OSAIC4$20.002026-06-30
SEC EDGAR: CIK 1828673 →
HCWB

HCW Biologics Inc.

HCWB
NasdaqSmall CapHealthcare

13F Pro Quality Score

30.3/100

Rank #2,493 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-5.22M

EPS (Diluted)

Q2 2026
EDGAR

$-11.58

Top Institutional Holders

as of Q2 2026
$515.7K total
JANE STREET GROUP, LLC
$260.2K+268.9%
CITADEL ADVISORS LLC
$99.5K-23.5%
HRT FINANCIAL LP
$67.0K-94.9%
VANGUARD FIDUCIARY TRUST CO
$32.5K+242.1%
Tower Research Capital LLC (TRC)
$20.5K-72.3%
Connective Capital Management, LLC
$16.7KNew
VANGUARD CAPITAL MANAGEMENT LLC
$10.0K-83.3%
Golden State Wealth Management, LLC
$8.3K-83.3%
BARCLAYS PLC
$953New
OSAIC HOLDINGS, INC.
$20-84.6%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…